Insulin syringe: difference between revisions
Diff·revision 15 → 16·13:06, 1 Feb 2025
Difference between revision 15 and revision 16 of Insulin syringe. 2 lines changed; the page grew by 334 bytes.
| Revision 15 — 15:00, 16 Jan 2025 UnitAuditUwe (talk) rm a duplicated category 3,777 bytes ±0 | Revision 16 — 13:06, 1 Feb 2025 MicrodoseMagnus (talk) fix the arithmetic in the worked reconstitution example 4,111 bytes +334 | ||
|---|---|---|---|
| 34 | The table is arithmetic, not guidance. It illustrates that a syringe marking corresponds to a mass only through a concentration, and that the concentration is itself uncertain unless the actual peptide mass in the vial is known — see [[Reconstitution of lyophilised peptides]] and [[Peptide content]].{{r|usp1503}} | 34 | The table is arithmetic, not guidance. It illustrates that a syringe marking corresponds to a mass only through a concentration, and that the concentration is itself uncertain unless the actual peptide mass in the vial is known — see [[Reconstitution of lyophilised peptides]] and [[Peptide content]].{{r|usp1503}} |
| 35 | 35 | ||
| + | 36 | The historical U-40 and U-500 insulin concentrations, with syringes scaled to match, are the reason the unit convention exists at all and the reason mismatched syringe and concentration have caused documented harm in insulin therapy. That history is why the convention is worth understanding rather than working around.{{r|ada2024}} | |
| + | 37 | ||
| 36 | == References == | 38 | == References == |
| 37 | {{reflist}} | 39 | {{reflist}} |